Shopping Cart 0
Cart Subtotal
AED 0

Global Childhood Absence Epilepsy Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 17910

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 26864

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 35819

Details

Childhood absence epilepsy (CAE), also known as pyknolepsy, is an idiopathic generalized epilepsy which occurs in otherwise normal children. The age of onset is between 4-10 years with peak age between 5-7 years. Children have absence seizures which although brief (~4-20 seconds), they occur frequently, sometimes in the hundreds per day. The absence seizures of CAE involve abrupt and severe impairment of consciousness. Mild automatisms are frequent, but major motor involvement early in the course excludes this diagnosis. The EEG demonstrates characteristic "typical 3Hz spike-wave" discharges. Prognosis is excellent in well-defined cases of CAE with most patients "growing out" of their epilepsy.

Scope of the Report:

The global Childhood Absence Epilepsy Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Childhood Absence Epilepsy Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Childhood Absence Epilepsy Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Childhood Absence Epilepsy Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers

Pfizer

GlaxoSmithKline

Cavion Inc

AbbVie

Teva Pharmaceutical

Insys Therapeutics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Ethosuximide

Valproate

Lamotrigine

CX-8998

Cannabidiol Oral Solution

Market Segment by Applications, can be divided into

Typical Absence Seizures

Atypical Absence Seizures

READ MORE

Table Of Content

Scope

Table of Contents

1 Childhood Absence Epilepsy Treatment Market Overview

1.1 Product Overview and Scope of Childhood Absence Epilepsy Treatment

1.2 Classification of Childhood Absence Epilepsy Treatment by Types

1.2.1 Global Childhood Absence Epilepsy Treatment Revenue Comparison by Types (2019-2024)

1.2.2 Global Childhood Absence Epilepsy Treatment Revenue Market Share by Types in 2018

1.2.3 Ethosuximide

1.2.4 Valproate

1.2.5 Lamotrigine

1.2.6 CX-8998

1.2.7 Cannabidiol Oral Solution

1.3 Global Childhood Absence Epilepsy Treatment Market by Application

1.3.1 Global Childhood Absence Epilepsy Treatment Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Typical Absence Seizures

1.3.3 Atypical Absence Seizures

1.4 Global Childhood Absence Epilepsy Treatment Market by Regions

1.4.1 Global Childhood Absence Epilepsy Treatment Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)

1.5 Global Market Size of Childhood Absence Epilepsy Treatment (2014-2024)

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 Childhood Absence Epilepsy Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.2 GlaxoSmithKline

2.2.1 Business Overview

2.2.2 Childhood Absence Epilepsy Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 GlaxoSmithKline Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.3 Cavion Inc

2.3.1 Business Overview

2.3.2 Childhood Absence Epilepsy Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Cavion Inc Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.4 AbbVie

2.4.1 Business Overview

2.4.2 Childhood Absence Epilepsy Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 AbbVie Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.5 Teva Pharmaceutical

2.5.1 Business Overview

2.5.2 Childhood Absence Epilepsy Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Teva Pharmaceutical Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.6 Insys Therapeutics

2.6.1 Business Overview

2.6.2 Childhood Absence Epilepsy Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Insys Therapeutics Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Childhood Absence Epilepsy Treatment Market Competition, by Players

3.1 Global Childhood Absence Epilepsy Treatment Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Childhood Absence Epilepsy Treatment Players Market Share

3.2.2 Top 10 Childhood Absence Epilepsy Treatment Players Market Share

3.3 Market Competition Trend

4 Global Childhood Absence Epilepsy Treatment Market Size by Regions

4.1 Global Childhood Absence Epilepsy Treatment Revenue and Market Share by Regions

4.2 North America Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

4.3 Europe Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

4.5 South America Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

5 North America Childhood Absence Epilepsy Treatment Revenue by Countries

5.1 North America Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)

5.2 USA Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

5.3 Canada Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

5.4 Mexico Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

6 Europe Childhood Absence Epilepsy Treatment Revenue by Countries

6.1 Europe Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)

6.2 Germany Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

6.3 UK Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

6.4 France Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

6.5 Russia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

6.6 Italy Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Childhood Absence Epilepsy Treatment Revenue by Countries

7.1 Asia-Pacific Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)

7.2 China Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

7.3 Japan Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

7.4 Korea Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

7.5 India Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

8 South America Childhood Absence Epilepsy Treatment Revenue by Countries

8.1 South America Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)

8.2 Brazil Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

8.3 Argentina Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

8.4 Colombia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Childhood Absence Epilepsy Treatment by Countries

9.1 Middle East and Africa Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)

9.2 Saudi Arabia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

9.3 UAE Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

9.4 Egypt Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

9.5 Nigeria Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

9.6 South Africa Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

10 Global Childhood Absence Epilepsy Treatment Market Segment by Type

10.1 Global Childhood Absence Epilepsy Treatment Revenue and Market Share by Type (2014-2019)

10.2 Global Childhood Absence Epilepsy Treatment Market Forecast by Type (2019-2024)

10.3 Ethosuximide Revenue Growth Rate (2014-2024)

10.4 Valproate Revenue Growth Rate (2014-2024)

10.5 Lamotrigine Revenue Growth Rate (2014-2024)

10.6 CX-8998 Revenue Growth Rate (2014-2024)

10.7 Cannabidiol Oral Solution Revenue Growth Rate (2014-2024)

11 Global Childhood Absence Epilepsy Treatment Market Segment by Application

11.1 Global Childhood Absence Epilepsy Treatment Revenue Market Share by Application (2014-2019)

11.2 Childhood Absence Epilepsy Treatment Market Forecast by Application (2019-2024)

11.3 Typical Absence Seizures Revenue Growth (2014-2019)

11.4 Atypical Absence Seizures Revenue Growth (2014-2019)

12 Global Childhood Absence Epilepsy Treatment Market Size Forecast (2019-2024)

12.1 Global Childhood Absence Epilepsy Treatment Market Size Forecast (2019-2024)

12.2 Global Childhood Absence Epilepsy Treatment Market Forecast by Regions (2019-2024)

12.3 North America Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

12.4 Europe Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

12.6 South America Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Childhood Absence Epilepsy Treatment Picture

Table Product Specifications of Childhood Absence Epilepsy Treatment

Table Global Childhood Absence Epilepsy Treatment and Revenue (Million USD) Market Split by Product Type

Figure Global Childhood Absence Epilepsy Treatment Revenue Market Share by Types in 2018

Figure Ethosuximide Picture

Figure Valproate Picture

Figure Lamotrigine Picture

Figure CX-8998 Picture

Figure Cannabidiol Oral Solution Picture

Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) by Application (2014-2024)

Figure Childhood Absence Epilepsy Treatment Revenue Market Share by Applications in 2018

Figure Typical Absence Seizures Picture

Figure Atypical Absence Seizures Picture

Table Global Market Childhood Absence Epilepsy Treatment Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Childhood Absence Epilepsy Treatment Type and Applications

Table Pfizer Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Childhood Absence Epilepsy Treatment Type and Applications

Table GlaxoSmithKline Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

Table Cavion Inc Basic Information, Manufacturing Base and Competitors

Table Cavion Inc Childhood Absence Epilepsy Treatment Type and Applications

Table Cavion Inc Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

Table AbbVie Basic Information, Manufacturing Base and Competitors

Table AbbVie Childhood Absence Epilepsy Treatment Type and Applications

Table AbbVie Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceutical Childhood Absence Epilepsy Treatment Type and Applications

Table Teva Pharmaceutical Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

Table Insys Therapeutics Basic Information, Manufacturing Base and Competitors

Table Insys Therapeutics Childhood Absence Epilepsy Treatment Type and Applications

Table Insys Therapeutics Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) by Players (2014-2019)

Table Global Childhood Absence Epilepsy Treatment Revenue Share by Players (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Players in 2017

Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Players in 2018

Figure Global Top 5 Players Childhood Absence Epilepsy Treatment Revenue Market Share in 2018

Figure Global Top 10 Players Childhood Absence Epilepsy Treatment Revenue Market Share in 2018

Figure Global Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) by Regions (2014-2019)

Table Global Childhood Absence Epilepsy Treatment Revenue Market Share by Regions (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue Market Share by Regions (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue Market Share by Regions in 2018

Figure North America Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Europe Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure South America Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Table North America Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)

Table North America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure North America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure North America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018

Figure USA Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Canada Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Mexico Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Table Europe Childhood Absence Epilepsy Treatment Revenue (Million USD) by Countries (2014-2019)

Figure Europe Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure Europe Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018

Figure Germany Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure UK Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure France Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Russia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Italy Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Childhood Absence Epilepsy Treatment Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018

Figure China Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Japan Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Korea Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure India Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Table South America Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)

Table South America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure South America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure South America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018

Figure Brazil Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Argentina Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Colombia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Childhood Absence Epilepsy Treatment Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018

Figure Saudi Arabia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure UAE Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Egypt Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Nigeria Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure South Africa Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) by Type (2014-2019)

Table Global Childhood Absence Epilepsy Treatment Revenue Share by Type (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Type (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Type in 2018

Table Global Childhood Absence Epilepsy Treatment Revenue Forecast by Type (2019-2024)

Figure Global Childhood Absence Epilepsy Treatment Market Share Forecast by Type (2019-2024)

Figure Global Ethosuximide Revenue Growth Rate (2014-2019)

Figure Global Valproate Revenue Growth Rate (2014-2019)

Figure Global Lamotrigine Revenue Growth Rate (2014-2019)

Figure Global CX-8998 Revenue Growth Rate (2014-2019)

Figure Global Cannabidiol Oral Solution Revenue Growth Rate (2014-2019)

Table Global Childhood Absence Epilepsy Treatment Revenue by Application (2014-2019)

Table Global Childhood Absence Epilepsy Treatment Revenue Share by Application (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Application (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Application in 2018

Table Global Childhood Absence Epilepsy Treatment Revenue Forecast by Application (2019-2024)

Figure Global Childhood Absence Epilepsy Treatment Market Share Forecast by Application (2019-2024)

Figure Global Typical Absence Seizures Revenue Growth Rate (2014-2019)

Figure Global Atypical Absence Seizures Revenue Growth Rate (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Childhood Absence Epilepsy Treatment Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

Figure Europe Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

Figure South America Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Pfizer

GlaxoSmithKline

Cavion Inc

AbbVie

Teva Pharmaceutical

Insys Therapeutics

Company Profile

Company Profile Title

Childhood absence epilepsy (CAE), also known as pyknolepsy, is an idiopathic generalized epilepsy which occurs in otherwise normal children. The age of onset is between 4-10 years with peak age between 5-7 years. Children have absence seizures which although brief (~4-20 seconds), they occur frequently, sometimes in the hundreds per day. The absence seizures of CAE involve abrupt and severe impairment of consciousness. Mild automatisms are frequent, but major motor involvement early in the course excludes this diagnosis. The EEG demonstrates characteristic "typical 3Hz spike-wave" discharges. Prognosis is excellent in well-defined cases of CAE with most patients "growing out" of their epilepsy.

Scope of the Report:

The global Childhood Absence Epilepsy Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Childhood Absence Epilepsy Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Childhood Absence Epilepsy Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Childhood Absence Epilepsy Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers

Pfizer

GlaxoSmithKline

Cavion Inc

AbbVie

Teva Pharmaceutical

Insys Therapeutics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Ethosuximide

Valproate

Lamotrigine

CX-8998

Cannabidiol Oral Solution

Market Segment by Applications, can be divided into

Typical Absence Seizures

Atypical Absence Seizures

READ MORE

Scope

Table of Contents

1 Childhood Absence Epilepsy Treatment Market Overview

1.1 Product Overview and Scope of Childhood Absence Epilepsy Treatment

1.2 Classification of Childhood Absence Epilepsy Treatment by Types

1.2.1 Global Childhood Absence Epilepsy Treatment Revenue Comparison by Types (2019-2024)

1.2.2 Global Childhood Absence Epilepsy Treatment Revenue Market Share by Types in 2018

1.2.3 Ethosuximide

1.2.4 Valproate

1.2.5 Lamotrigine

1.2.6 CX-8998

1.2.7 Cannabidiol Oral Solution

1.3 Global Childhood Absence Epilepsy Treatment Market by Application

1.3.1 Global Childhood Absence Epilepsy Treatment Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Typical Absence Seizures

1.3.3 Atypical Absence Seizures

1.4 Global Childhood Absence Epilepsy Treatment Market by Regions

1.4.1 Global Childhood Absence Epilepsy Treatment Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)

1.5 Global Market Size of Childhood Absence Epilepsy Treatment (2014-2024)

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 Childhood Absence Epilepsy Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.2 GlaxoSmithKline

2.2.1 Business Overview

2.2.2 Childhood Absence Epilepsy Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 GlaxoSmithKline Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.3 Cavion Inc

2.3.1 Business Overview

2.3.2 Childhood Absence Epilepsy Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Cavion Inc Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.4 AbbVie

2.4.1 Business Overview

2.4.2 Childhood Absence Epilepsy Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 AbbVie Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.5 Teva Pharmaceutical

2.5.1 Business Overview

2.5.2 Childhood Absence Epilepsy Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Teva Pharmaceutical Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.6 Insys Therapeutics

2.6.1 Business Overview

2.6.2 Childhood Absence Epilepsy Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Insys Therapeutics Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Childhood Absence Epilepsy Treatment Market Competition, by Players

3.1 Global Childhood Absence Epilepsy Treatment Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Childhood Absence Epilepsy Treatment Players Market Share

3.2.2 Top 10 Childhood Absence Epilepsy Treatment Players Market Share

3.3 Market Competition Trend

4 Global Childhood Absence Epilepsy Treatment Market Size by Regions

4.1 Global Childhood Absence Epilepsy Treatment Revenue and Market Share by Regions

4.2 North America Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

4.3 Europe Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

4.5 South America Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

5 North America Childhood Absence Epilepsy Treatment Revenue by Countries

5.1 North America Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)

5.2 USA Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

5.3 Canada Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

5.4 Mexico Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

6 Europe Childhood Absence Epilepsy Treatment Revenue by Countries

6.1 Europe Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)

6.2 Germany Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

6.3 UK Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

6.4 France Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

6.5 Russia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

6.6 Italy Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Childhood Absence Epilepsy Treatment Revenue by Countries

7.1 Asia-Pacific Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)

7.2 China Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

7.3 Japan Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

7.4 Korea Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

7.5 India Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

8 South America Childhood Absence Epilepsy Treatment Revenue by Countries

8.1 South America Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)

8.2 Brazil Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

8.3 Argentina Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

8.4 Colombia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Childhood Absence Epilepsy Treatment by Countries

9.1 Middle East and Africa Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)

9.2 Saudi Arabia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

9.3 UAE Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

9.4 Egypt Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

9.5 Nigeria Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

9.6 South Africa Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

10 Global Childhood Absence Epilepsy Treatment Market Segment by Type

10.1 Global Childhood Absence Epilepsy Treatment Revenue and Market Share by Type (2014-2019)

10.2 Global Childhood Absence Epilepsy Treatment Market Forecast by Type (2019-2024)

10.3 Ethosuximide Revenue Growth Rate (2014-2024)

10.4 Valproate Revenue Growth Rate (2014-2024)

10.5 Lamotrigine Revenue Growth Rate (2014-2024)

10.6 CX-8998 Revenue Growth Rate (2014-2024)

10.7 Cannabidiol Oral Solution Revenue Growth Rate (2014-2024)

11 Global Childhood Absence Epilepsy Treatment Market Segment by Application

11.1 Global Childhood Absence Epilepsy Treatment Revenue Market Share by Application (2014-2019)

11.2 Childhood Absence Epilepsy Treatment Market Forecast by Application (2019-2024)

11.3 Typical Absence Seizures Revenue Growth (2014-2019)

11.4 Atypical Absence Seizures Revenue Growth (2014-2019)

12 Global Childhood Absence Epilepsy Treatment Market Size Forecast (2019-2024)

12.1 Global Childhood Absence Epilepsy Treatment Market Size Forecast (2019-2024)

12.2 Global Childhood Absence Epilepsy Treatment Market Forecast by Regions (2019-2024)

12.3 North America Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

12.4 Europe Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

12.6 South America Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Childhood Absence Epilepsy Treatment Picture

Table Product Specifications of Childhood Absence Epilepsy Treatment

Table Global Childhood Absence Epilepsy Treatment and Revenue (Million USD) Market Split by Product Type

Figure Global Childhood Absence Epilepsy Treatment Revenue Market Share by Types in 2018

Figure Ethosuximide Picture

Figure Valproate Picture

Figure Lamotrigine Picture

Figure CX-8998 Picture

Figure Cannabidiol Oral Solution Picture

Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) by Application (2014-2024)

Figure Childhood Absence Epilepsy Treatment Revenue Market Share by Applications in 2018

Figure Typical Absence Seizures Picture

Figure Atypical Absence Seizures Picture

Table Global Market Childhood Absence Epilepsy Treatment Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Childhood Absence Epilepsy Treatment Type and Applications

Table Pfizer Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Childhood Absence Epilepsy Treatment Type and Applications

Table GlaxoSmithKline Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

Table Cavion Inc Basic Information, Manufacturing Base and Competitors

Table Cavion Inc Childhood Absence Epilepsy Treatment Type and Applications

Table Cavion Inc Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

Table AbbVie Basic Information, Manufacturing Base and Competitors

Table AbbVie Childhood Absence Epilepsy Treatment Type and Applications

Table AbbVie Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceutical Childhood Absence Epilepsy Treatment Type and Applications

Table Teva Pharmaceutical Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

Table Insys Therapeutics Basic Information, Manufacturing Base and Competitors

Table Insys Therapeutics Childhood Absence Epilepsy Treatment Type and Applications

Table Insys Therapeutics Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)

Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) by Players (2014-2019)

Table Global Childhood Absence Epilepsy Treatment Revenue Share by Players (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Players in 2017

Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Players in 2018

Figure Global Top 5 Players Childhood Absence Epilepsy Treatment Revenue Market Share in 2018

Figure Global Top 10 Players Childhood Absence Epilepsy Treatment Revenue Market Share in 2018

Figure Global Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) by Regions (2014-2019)

Table Global Childhood Absence Epilepsy Treatment Revenue Market Share by Regions (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue Market Share by Regions (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue Market Share by Regions in 2018

Figure North America Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Europe Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure South America Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Table North America Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)

Table North America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure North America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure North America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018

Figure USA Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Canada Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Mexico Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Table Europe Childhood Absence Epilepsy Treatment Revenue (Million USD) by Countries (2014-2019)

Figure Europe Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure Europe Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018

Figure Germany Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure UK Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure France Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Russia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Italy Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Childhood Absence Epilepsy Treatment Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018

Figure China Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Japan Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Korea Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure India Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Table South America Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)

Table South America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure South America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure South America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018

Figure Brazil Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Argentina Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Colombia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Childhood Absence Epilepsy Treatment Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018

Figure Saudi Arabia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure UAE Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Egypt Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure Nigeria Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Figure South Africa Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)

Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) by Type (2014-2019)

Table Global Childhood Absence Epilepsy Treatment Revenue Share by Type (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Type (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Type in 2018

Table Global Childhood Absence Epilepsy Treatment Revenue Forecast by Type (2019-2024)

Figure Global Childhood Absence Epilepsy Treatment Market Share Forecast by Type (2019-2024)

Figure Global Ethosuximide Revenue Growth Rate (2014-2019)

Figure Global Valproate Revenue Growth Rate (2014-2019)

Figure Global Lamotrigine Revenue Growth Rate (2014-2019)

Figure Global CX-8998 Revenue Growth Rate (2014-2019)

Figure Global Cannabidiol Oral Solution Revenue Growth Rate (2014-2019)

Table Global Childhood Absence Epilepsy Treatment Revenue by Application (2014-2019)

Table Global Childhood Absence Epilepsy Treatment Revenue Share by Application (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Application (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Application in 2018

Table Global Childhood Absence Epilepsy Treatment Revenue Forecast by Application (2019-2024)

Figure Global Childhood Absence Epilepsy Treatment Market Share Forecast by Application (2019-2024)

Figure Global Typical Absence Seizures Revenue Growth Rate (2014-2019)

Figure Global Atypical Absence Seizures Revenue Growth Rate (2014-2019)

Figure Global Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Childhood Absence Epilepsy Treatment Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

Figure Europe Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

Figure South America Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Pfizer

GlaxoSmithKline

Cavion Inc

AbbVie

Teva Pharmaceutical

Insys Therapeutics